10 | LipopolysaccharidesIBA
01/2022
-
01/2012 |
9 | 20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
01/2022
-
05/2010 |
7 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2019
-
05/2010 |
7 | Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2019
-
11/2010 |
7 | Vasodilator Agents (Vasodilators)IBA
01/2019
-
05/2010 |
6 | Proteins (Proteins, Gene)FDA Link
01/2021
-
05/2010 |
6 | Nitric Oxide Synthase (NO Synthase)IBA
12/2019
-
05/2010 |
5 | N-(20-hydroxyeicosa-5,14-dienoyl)glycineIBA
01/2022
-
05/2010 |
5 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2019
-
09/2011 |
5 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2018
-
01/2012 |
4 | TOR Serine-Threonine KinasesIBA
01/2022
-
05/2017 |
4 | Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2022
-
01/2012 |
4 | CytokinesIBA
03/2021
-
01/2012 |
4 | EnzymesIBA
01/2018
-
01/2012 |
4 | Peroxynitrous Acid (Peroxynitrite)IBA
05/2017
-
04/2011 |
3 | Desoxycorticosterone (Deoxycorticosterone)IBA
01/2022
-
12/2010 |
3 | Desoxycorticosterone Acetate (DOCA)FDA Link
01/2022
-
12/2010 |
3 | Sirolimus (Rapamycin)FDA Link
01/2022
-
12/2019 |
3 | SaltsIBA
01/2022
-
12/2010 |
3 | InflammasomesIBA
01/2021
-
04/2017 |
3 | Epoxide HydrolasesIBA
01/2021
-
04/2013 |
3 | Vasoconstrictor AgentsIBA
12/2019
-
05/2010 |
3 | Arachidonic Acid (Vitamin F)IBA
12/2019
-
05/2010 |
3 | EndotoxinsIBA
12/2019
-
09/2011 |
3 | EicosanoidsIBA
12/2019
-
01/2012 |
3 | ZymosanIBA
01/2019
-
01/2018 |
3 | ProstaglandinsIBA
07/2013
-
05/2010 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
08/2012
-
10/2010 |
3 | Angiotensin IIIBA
08/2012
-
10/2010 |
3 | 2,4,3',5'-tetramethoxystilbeneIBA
08/2012
-
10/2010 |
2 | Acetates (Acetic Acid Esters)FDA Link
01/2022
-
12/2010 |
2 | Bexarotene (LGD1069)FDA Link
03/2021
-
02/2018 |
2 | Caspase 1 (ICE Protease)IBA
01/2021
-
04/2017 |
2 | NucleotidesIBA
01/2021
-
04/2017 |
2 | NitrogenIBA
12/2019
-
01/2012 |
2 | Oxygen (Dioxygen)IBA
12/2019
-
01/2012 |
2 | Protein Isoforms (Isoforms)IBA
12/2019
-
04/2017 |
2 | Syk KinaseIBA
01/2019
-
01/2018 |
2 | 2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamideIBA
01/2019
-
01/2018 |
2 | NADP (NADPH)IBA
02/2018
-
04/2017 |
2 | NADPH Oxidases (NAD(P)H oxidase)IBA
02/2018
-
08/2012 |
2 | Peroxidase (Myeloperoxidase)IBA
01/2018
-
05/2017 |
2 | CaspasesIBA
04/2017
-
01/2012 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022 |
1 | bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
09/2021 |
1 | Caspase 3 (Caspase-3)IBA
09/2021 |
1 | Neuroprotective AgentsIBA
03/2021 |
1 | 14,15-dihydroxyeicosatrienoic acidIBA
01/2021 |
1 | InterleukinsIBA
01/2021 |
1 | Histamine (Histamine Dihydrochloride)FDA Link
12/2019 |
1 | Serotonin (5 Hydroxytryptamine)IBA
12/2019 |
1 | BradykininIBA
12/2019 |
1 | Interleukin-8 (Interleukin 8)IBA
01/2019 |
1 | Phosphotransferases (Kinase)IBA
02/2018 |
1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2018 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2018 |
1 | Toll-Like Receptors (Toll-Like Receptor)IBA
01/2018 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018 |
1 | Ribosomal Protein S6IBA
05/2017 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017 |
1 | Epoprostenol (Prostacyclin)FDA LinkGeneric
05/2017 |
1 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2017 |
1 | Toll-Like Receptor 4IBA
05/2017 |
1 | 3-nitrotyrosineIBA
04/2017 |
1 | Oxidoreductases (Dehydrogenase)IBA
04/2017 |
1 | N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
04/2017 |
1 | Leucine-Rich Repeat ProteinsIBA
04/2017 |
1 | Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2016 |
1 | 4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
09/2013 |
1 | Superoxides (Superoxide)IBA
09/2013 |
1 | Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
09/2013 |
1 | Soluble Guanylyl CyclaseIBA
09/2013 |
1 | N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
07/2013 |
1 | Dinoprostone (PGE2)FDA Link
07/2013 |